U.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

The U.S and Asia Markets for Bone Morphogenic Proteins (BMP) in Spine Fusion report includes viewpoints from medical device companies, surgeons, healthcare organizations, and scientists on this emerging market. The parameters of the BMP market are forecast for the period 2004 to 2008 with 2003 as base year.

Table of Contents

U.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion, Total Bone Morphogenic Protein (BMP) in Spine Fusion MarketOverviewExecutive SummaryAnatomy of Human SpineLow Back Pain & other Spinal DisordersTreatment of Spinal PathologiesSpinal Fusion and role of Bone Morphogenic Proteins (BMP)The Importance of Surgical Approach in Low-back fusionsForecast MethodologyMarket Trends and ForecastsMarket DriversMarket RestraintsRevenue ForecastsReimbursement IssuesCost of BMPProcedure Code for BMP UseReimbursement Policies of Private Healthcare OrganizationsMedicareCompetitive AnalysisMajor PlayersPatents- Market Closed to New Entrants?Surgical IndicationsDevelopment StatusRegulatory EnvironmentSurgeon OpinionsFrost & Sullivan AwardsTechnology Leadership AwardMarket Leadership AwardU.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion, Bone Morphogenic Proteins (BMP) in Spine FusionForecasts for the Spine Fusion MarketSource of DataComparison with Previous Frost & Sullivan Research ServicesTotal Number of Spine Fusion ProceduresSpine Fusion Procedures by Geographic RegionSpine Fusion Procedures by AnatomyAnterior (ALIF) and Posterior (PLIF) Lumbar Interbody Fusion ProceduresForecasts for the BMP MarketIntroductionProcedural and Unit ForecastPricing ForecastRevenue ForecastMedtronic InfuseHistory of DevelopmentDescriptionPre-Clinical and Clinical StudiesFDA Indications and ContraindicationsFDA Warnings and PrecautionsFuture DevelopmentsStrategic Recommendations for MedtronicStryker Biotech OP-1History of DevelopmentDescriptionPre-Clinical and Clinical StudiesFDA Indications and ContraindicationsFDA Warnings and PrecautionsFuture DevelopmentsStrategic Recommendations for StrykerDePuy Spine MP52History of DevelopmentDescriptionPre-Clinical and Clinical StudiesFDA StatusStrategic Recommendations for DePuy SpineProduct Comparisons- Infuse, OP-1 and MP52SummaryU.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion, Reimbursement IssuesPrivate Healthcare OrganizationsAetnaKaiser PermanenteAnthemEmpire Blue Cross Blue ShieldBlue Cross Blue Shield of IllinoisWellPoint Health NetworksCenters for Medicare & Medicaid Services (CMS)Reimbursement PolicyU.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion, Surgeon's CornerBMP in spine practiceOverviewCurrent standard of careSurgeon's Preference among Infuse OP-1 and MP52Patient Selection & Price FactorSurgical TechniqueWill BMP use cannibalize traditional spinal implant application?BMP Usage in Other Regions of SpineEffect of Non-fusion Technologies on BMP UsageU.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion, Asian PerspectiveSurgeons' OpinionsSurgeon InterviewsHow will BMP Make a Difference to Spine Surgeons in Asia?Surgical TechniqueInfluence of PriceAustraliaImportant StatisticsMarket size for spine fusionsPricing of Spinal implant and BMP productsStatus of BMP products in the marketChinaImportant StatisticsMarket size for Spine fusionsPricing of Spinal Implants and BMP ProductsStatus of BMP Products in the MarketIndiaImportant StatisticsMarket Size for Spine FusionPricing of Spinal Implants and BMP ProductsStatus of BMP Products in the MarketJapanImportant StatisticsMarket Size for Spine FusionPricing of Spinal implant and BMP productsStatus of BMP Products in the MarketSouth KoreaImportant StatisticsMarket size for spine fusionsPricing of Spinal implant and BMP productsStatus of BMP products in the market




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.